© 1992 by Oxford University Press
Recommendations on Predictive Testing for Germ Line p53 Mutations Among Cancer-Prone Individuals
Frederick P. Li, Judy E. Garber, Stephen H. Friend, Louise C. Strong, Andrea F. Patenaude, Eric T. Juengst, Philip R. Reilly, Pelayo Correa, and Joseph F. Fraumeni, Jr.
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Physiology..Humans
- Oncology..Ethical Issues
- Oncology..Genetic Causes of Cancer
- Oncology..p53
- Oncology..Policy and Patient Care Issues for Retinoblastoma
- Oncology..Hereditary Causes of Retinoblastoma
- Oncology..Environmental Causes of Cancer
- Oncology..Human Genome
- Medicine..Retinoblastoma
- Oncology..Epidemiology, Causes, and Risks of Retinoblastoma
- Religious Studies..Ethics
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Masciari, A. D. Van den Abbeele, L. R. Diller, I. Rastarhuyeva, J. Yap, K. Schneider, L. Digianni, F. P. Li, J. F. Fraumeni Jr, S. Syngal, et al. F18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome JAMA, March 19, 2008; 299(11): 1315 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Bond, K. M. Hirshfield, T. Kirchhoff, G. Alexe, E. E. Bond, H. Robins, F. Bartel, H. Taubert, P. Wuerl, W. Hait, et al. MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner. Cancer Res., May 15, 2006; 66(10): 5104 - 5110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Offit, E. Groeger, S. Turner, E. A. Wadsworth, and M. A. Weiser The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks JAMA, September 22, 2004; 292(12): 1469 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. CHOMPRET, A. ABEL, D. STOPPA-LYONNET, L. BRUGIÈRES, S. PAGÈS, J. FEUNTEUN, and C. BONAÏTI-PELLIÉ Sensitivity and predictive value of criteria for p53 germline mutation screening J. Med. Genet., January 1, 2001; 38(1): 43 - 47. [Full Text]
|
|
|
|
 |
|
 R. E. Buller, A. K. Sood, T. Lallas, T. Buekers, and J. S. Skilling Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer J Natl Cancer Inst, February 17, 1999; 91(4): 339 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Li Cancer Control in Susceptible Groups: Opportunities and Challenges J. Clin. Oncol., January 1, 1999; 17(2): 719 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. McKinnon, B. J. Baty, R. L. Bennett, M. Magee, W. A. Neufeld-Kaiser, K. F. Peters, J. C. Sawyer, and K. A. Schneider Predisposition Genetic Testing for Late-Onset Disorders in Adults: A Position Paper of the National Society of Genetic Counselors JAMA, October 15, 1997; 278(15): 1217 - 1220. [Abstract] [PDF]
|
|
|
|
|
|
G. Geller, J. R. Botkin, M. J. Green, N. Press, B. B. Biesecker, B. Wilfond, G. Grana, M. B. Daly, K. Schneider, and M. J. E. Kahn Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent JAMA, May 14, 1997; 277(18): 1467 - 1474. [Abstract] [PDF]
|
|
|
|
|
|
K. F. Hoskins, J. E. Stopfer, K. A. Calzone, S. D. Merajver, T. R. Rebbeck, J. E. Garber, and B. L. Weber Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians JAMA, February 15, 1995; 273(7): 577 - 585. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Lerman and R. Croyle Psychological Issues in Genetic Testing for Breast Cancer Susceptibility Arch Intern Med, March 28, 1994; 154(6): 609 - 616. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Fost Genetic Diagnosis and Treatment: Ethical Considerations Arch Pediatr Adolesc Med, November 1, 1993; 147(11): 1190 - 1195. [Abstract] [PDF]
|
|
|
|
 |
|
 C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text]
|
|
|
|
|
|
B. B. Biesecker, M. Boehnke, K. Calzone, D. S. Markel, J. E. Garber, F. S. Collins, and B. L. Weber Genetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer JAMA, April 21, 1993; 269(15): 1970 - 1974. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||